AI-Digital-Physical Convergence in Drug Discovery

This white paper explores the integration of AI and digital tools in the drug discovery and development process, emphasizing the DMTA cycle. It highlights the challenges of manual data transfer and the benefits of a digital-physical virtuous cycle for enhancing productivity, quality assurance, and regulatory compliance in pharmaceutical R&D.